DARWIN BIOTECH
LIVE

Serial Number

79458018

Owner

Darwin Biotechnology (Hubei) Co., Ltd.

Filing Date

May 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DARWIN BIOTECH Trademark

Serial Number: 79458018

DARWIN BIOTECH is a trademark filed by Darwin Biotechnology (Hubei) Co., Ltd. on May 22, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Darwin Biotechnology (Hubei) Co., Ltd.

Room 06, 1st Floor, Building A12, Phase II,

Entity Type: 98

Trademark Details

Filing Date

May 22, 2026

Registration Date

Not Registered

Goods & Services

Medical apparatus and instruments for treating cardiovascular disease; manually-operated exercise equipment for physical therapy purposes; massage apparatus [for medical purposes]; apparatus for the regeneration of stem cells for medical purposes; nerve stimulator apparatus; surgical implants comprising artificial material.

Advertising services; organization of exhibitions for commercial or advertising purposes; updating of advertising material; online advertising on a computer network; production of advertising films; sales promotion for others; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; demonstration of goods; business management consultancy; negotiation and conclusion of commercial transactions for third parties.

Reagent paper for medical purposes; pharmaceutical preparations for the treatment of neurodegeneration; preparations of microorganisms for medical purposes; cultures of microorganisms for medical or veterinary use; pharmaceutical preparations for the treatment of Amyotrophic lateral sclerosis; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for wounds; medicines for the treatment of cardiovascular and cerebrovascular diseases; biological tissue cultures for medical purposes; stem cells for medical purposes.

Cell free protein synthesis technology research; biochemical research and analysis; development of pharmaceutical preparations and medicines; research and development of new products; product safety testing services; scientific investigation for medical purposes; chemical research and analysis; DNA screening for scientific research purposes; research of induced pluripotent stem cells; stem cell research services.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 8, 2026 RFCR
NON-FINAL ACTION WRITTEN
Oct 7, 2026 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 5, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 5, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 5, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2026 REPR